Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

296.82 +1.27 (+0.43%)
Streaming Delayed Price Updated: 3:41 PM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
56 57 Next >
What the Options Market Tells Us About Amgen
 
Via Benzinga
Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy?
These two stocks could be rivals in the intense GLP-1 space in the future. 
Via The Motley Fool
Can These 5 Assets Skyrocket Your Portfolio?
Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look. 
Via Talk Markets
Topics ETFs Stocks
Interesting Technical Analysis finding for AMGEN INC (NASDAQ:AMGN)
NASDAQ:AMGN Shows Potential for a Breakout. 
Via Chartmill
Where Will Amgen Be in 5 Years?
There are plenty of ongoing positive developments with the biotech giant. 
Via The Motley Fool
Behind the Scenes of Amgen's Latest Options Trends
 
Via Benzinga
(AMGN) - Analyzing Amgen's Short Interest
 
Via Benzinga
Amgen Unusual Options Activity For August 29
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
The Bull Market Strengthened, Let The Naysayers Say Nay...
Being able to recite the potential problems in the world does not make you a good investor. 
Via Talk Markets
Time To Invest And Or Trade In Bio-Tech Stocks?
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... 
Via Talk Markets
Topics ETFs
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500
Growth-oriented businesses can make excellent additions to a well-diversified portfolio. 
Via The Motley Fool
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
Amgen is a decently valued stock that has an excellent business and also gives investors a way to potentially gain exposure to a lucrative weight loss market. 
Via The Motley Fool
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. 
Via Benzinga
Viridian Spikes On A 'Bull-Case Scenario' For Eye Drug Considered Amgen Rival
The results are also promising for the next-generation version of that drug. 
Via Investor's Business Daily
Growth At Any Price (GAAP) Is A Bad Strategy. Valuation Matters.
The current leadership in the stock market is clearly not tech, or the Magnificent 7. 
Via Talk Markets
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation. Other drugs also affected. 
Via Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly higher than those in other wealthy nations, with some prices still more than... 
Via Benzinga
Topics Economy
Patchy But Still Bullish
Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations. 
Via Talk Markets
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
The race to develop the next big obesity treatment is on with leaders Lilly and Novo trying to keep their top slots. 
Via Investor's Business Daily
Intuit, Amgen And Sprott Uranium Miners ETF: CNBC's 'Final Trades'
Jason Snipe of Odyssey Capital Advisors likes Intuit Inc., after the company beat on the top and bottom lines, but missed on guidance. 
Via Benzinga
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
The single-dose vials will also increase supply, the drug giant says. 
Via Investor's Business Daily
Eli Lilly’s Path to the Next Trillion Market Capitalization
Eli Lilly and Co. (NYSE: LLY) is a pharmaceutical giant that's made headlines for its GLP-1/GIP weight loss drug Tirzepatide, aka Mounjaro, for Type 2 diabetes. 
Via MarketBeat
3 Unstoppable Dividend Stocks to Buy Right Now
These stocks are the A-team for income investors. 
Via The Motley Fool
US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks
The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the recent gains could keep traders wary of a potential pullback. 
Via Benzinga
Topics Stocks
ProInvestor Insights - August 2024
Our August newletter features insights from high-level Wall Street researchers, traders, analysts, and economists that you won’t find anywhere else. And AAII’s first-to-be-seen interview with legendary... 
Via Talk Markets
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
Investors seeking reliable dividend growth want to start with these two members of the Dow Jones Industrial Average. 
Via The Motley Fool
Topics Stocks
This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the Pipeline
Amgen has many growth opportunities ahead, and it also pays a fairly high dividend. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations
The unveiled prices follow months of back-and-forth negotiation between the government and the companies. 
Via Investor's Business Daily
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.